Angiotensin II receptor blockers in dermatology: a narrative review

J Dermatolog Treat. 2022 Nov;33(7):2894-2898. doi: 10.1080/09546634.2022.2089332. Epub 2022 Jun 27.

Abstract

Angiotensin II receptor blockers (ARBs) are commonly used for cardiovascular diseases, especially for patients who can't tolerate the side effects of cough and angioedema caused by angiotensin converting enzyme inhibitors (ACEIs). However, the evidence of using ARBs in dermatology is mostly anecdotal and limited to case reports or small case series. Here we present a narrative review focusing on the therapeutic use of ARBs in dermatology and adverse cutaneous reactions due to the administration of ARBs.

Keywords: Angiotensin receptor blockers; adverse drug reaction; cutaneous reaction; dermatology; treatment.

Publication types

  • Review

MeSH terms

  • Administration, Cutaneous
  • Angiotensin Receptor Antagonists / adverse effects
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects
  • Cardiovascular Diseases*
  • Dermatology*
  • Humans

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors